Reviewing Biohaven Pharmaceutical Holding Company Ltd. (BHVN)’s and Intec Pharma Ltd. (NASDAQ:NTEC)’s results

Both Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) and Intec Pharma Ltd. (NASDAQ:NTEC) are each other’s competitor in the Biotechnology industry. Thus the compare of their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation.

Earnings and Valuation

We can see in table 1 the earnings per share, top-line revenue and valuation of Biohaven Pharmaceutical Holding Company Ltd. and Intec Pharma Ltd.

Profitability

Table 2 demonstrates the return on assets, net margins and return on equity of Biohaven Pharmaceutical Holding Company Ltd. and Intec Pharma Ltd.

Analyst Recommendations

The following table delivered below contains the ratings and recommendations for Biohaven Pharmaceutical Holding Company Ltd. and Intec Pharma Ltd.

$83.6 is Biohaven Pharmaceutical Holding Company Ltd.’s consensus target price while its potential upside is 32.26%.

Insider and Institutional Ownership

The shares of both Biohaven Pharmaceutical Holding Company Ltd. and Intec Pharma Ltd. are owned by institutional investors at 91.4% and

... read more at: https://cryptocoinstribune.com/reviewing-biohaven-pharmaceutical-holding-company-ltd-bhvns-and-intec-pharma-ltd-nasdaqntecs-results/

Leave a Reply